What Did the Research Discover? Researchers in Japan conducted a large online survey with 10,000 adults to study how common belching disorders are and what factors might be linked to them. The study found that 1.5% of participants (151 people) had belching disorders. These conditions, which cause frequent and bothersome belching, are classified as gastroduodenal...
What Did the Research Discover? High blood pressure (hypertension) is a major risk factor for heart disease, stroke, and kidney disease. While experts have developed guidelines to help manage hypertension, recent data show that blood pressure control in the U.S. is getting worse instead of better. From 1999 to 2014, blood pressure control improved, but since then,...
What Did the Research Discover? Researchers investigated whether COVID-19 infection increases the long-term risk of developing autoimmune and autoinflammatory connective tissue disorders. The study included 6,912,427 participants in South Korea, with 3,145,388 individuals who had COVID-19 and 3,767,039 who did not. The participants were followed for at least 180...
For Immediate Release: March 07, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Wednesday, the FDA approved Encelto (revakinagene taroretcel-lwey), an allogeneic encapsulated cell-based gene therapy for the treatment of adults with idiopathic macular telangiectasia type 2 (MacTel). MacTel is a...
For Immediate Release: March 04, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Monday, the FDA approved the first generics of Xarelto (rivaroxaban), 2.5 mg, tablets to reduce the risk of major cardiovascular events in adult patients with coronary artery disease (CAD) and to reduce the risk of...
For Immediate Release: January 16, 2025 Today, the U.S. Food and Drug Administration authorized the marketing of 20 ZYN nicotine pouch products through the premarket tobacco product application (PMTA) pathway following an extensive scientific review. This is the first time the agency has authorized products commonly referred to as nicotine pouches, which are small...